| Lastest Insider Transactions Of Entrada Therapeutics, Inc. ( TRDA ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| TRDA | Entrada Therapeutics, Inc. | PARMAR KUSH | Directior | 2026-08-06 | Sell | 155,255 | 6.95 | 1,078,938 | 2026-08-10 19:54:40 |
| TRDA | Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | 10% Owner | 2026-08-06 | Sell | 62,811 | 6.88 | 431,829 | 2026-08-10 19:52:46 |
| TRDA | Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | 10% Owner | 2026-07-30 | Sell | 116,474 | 6.93 | 807,027 | 2026-08-03 17:32:54 |
| TRDA | Entrada Therapeutics, Inc. | PARMAR KUSH | Directior 10% Owner | 2026-07-30 | Sell | 116,474 | 6.93 | 807,027 | 2026-08-03 17:26:41 |
| TRDA | Entrada Therapeutics, Inc. | Zeiher Bernhardt G | Directior | 2026-05-20 | Buy | 5,000 | 5.86 | 29,316 | 2026-05-21 16:31:31 |
| TRDA | Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | 2026-05-04 | Sell | 25,907 | 15.39 | 398,810 | 2026-05-04 19:25:01 |
| TRDA | Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | 2026-05-04 | Sell | 15,000 | 15.33 | 229,953 | 2026-05-04 19:24:16 |
| TRDA | Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | 2026-05-04 | Option Exercise | 15,000 | 1.74 | 26,100 | 2026-05-04 19:24:16 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2026-04-01 | Sell | 2,500 | 12.95 | 32,375 | 2026-04-02 16:39:16 |
| TRDA | Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | 2026-03-09 | Sell | 15,010 | 13.04 | 195,771 | 2026-03-11 16:35:13 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2026-03-09 | Sell | 16,477 | 13.01 | 214,379 | 2026-03-11 16:34:08 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2026-03-04 | Sell | 7,988 | 12.25 | 97,892 | 2026-03-06 16:36:45 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2025-11-21 | Sell | 8,910 | 9.98 | 88,932 | 2025-11-24 16:30:41 |
| TRDA | Entrada Therapeutics, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | 2025-11-20 | Buy | 28,867 | 9.07 | 261,846 | 2025-11-24 16:09:49 |
| TRDA | Entrada Therapeutics, Inc. | PARMAR KUSH | Directior 10% Owner | 2025-11-14 | Sell | 200,000 | 8.80 | 1,760,000 | 2025-11-18 16:36:30 |
| TRDA | Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | 10% Owner | 2025-11-14 | Sell | 200,000 | 8.80 | 1,760,000 | 2025-11-18 16:34:52 |
| TRDA | Entrada Therapeutics, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | 2025-11-10 | Buy | 178,044 | 7.60 | 1,352,587 | 2025-11-12 17:34:18 |
| TRDA | Entrada Therapeutics, Inc. | PARMAR KUSH | Directior 10% Owner | 2025-07-09 | Sell | 27,000 | 7.50 | 202,554 | 2025-07-11 17:27:03 |
| TRDA | Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | 10% Owner | 2025-07-09 | Sell | 27,000 | 7.50 | 202,554 | 2025-07-11 17:25:21 |
| TRDA | Entrada Therapeutics, Inc. | PARMAR KUSH | Directior 10% Owner | 2025-06-27 | Sell | 125,000 | 6.93 | 866,633 | 2025-07-01 20:33:41 |
| TRDA | Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | 10% Owner | 2025-06-27 | Sell | 125,000 | 6.93 | 866,633 | 2025-07-01 20:32:14 |
| TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Directior | 2024-05-13 | Buy | 50,000 | 14.63 | 731,683 | 2025-06-18 16:32:46 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2025-03-17 | Sell | 1,784 | 10.67 | 19,035 | 2025-03-19 16:32:26 |
| TRDA | Entrada Therapeutics, Inc. | MPM BIOVENTURES 2018, L.P. | 10% Owner | 2024-12-10 | Sell | 44,722 | 20.51 | 917,111 | 2024-12-12 17:00:22 |
| TRDA | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% Owner | 2024-12-10 | Sell | 44,722 | 20.51 | 917,111 | 2024-12-12 17:00:18 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2024-11-29 | Sell | 6,000 | 19.99 | 119,948 | 2024-12-03 17:26:25 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2024-11-29 | Option Exercise | 6,000 | 2.10 | 12,600 | 2024-12-03 17:26:25 |
| TRDA | Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | 2024-11-29 | Sell | 15,891 | 20.18 | 320,620 | 2024-12-03 17:24:50 |
| TRDA | Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | 2024-11-11 | Sell | 4,109 | 20.03 | 82,300 | 2024-11-13 16:49:06 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2024-11-11 | Sell | 8,637 | 19.98 | 172,562 | 2024-11-13 16:47:06 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2024-11-11 | Option Exercise | 6,000 | 2.10 | 12,600 | 2024-11-13 16:47:06 |
| TRDA | Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | 2024-11-04 | Sell | 18,219 | 18.62 | 339,281 | 2024-11-06 16:36:50 |
| TRDA | Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | 2024-10-16 | Sell | 600 | 18.00 | 10,800 | 2024-10-18 16:31:39 |
| TRDA | Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | 2024-09-26 | Sell | 847 | 16.00 | 13,552 | 2024-09-30 16:32:11 |
| TRDA | Entrada Therapeutics, Inc. | Sethuraman Natarajan | Chief Scientific Officer | 2024-07-12 | Sell | 1,238 | 18.00 | 22,284 | 2024-07-16 16:43:46 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO | 2024-07-12 | Sell | 1,900 | 17.84 | 33,897 | 2024-07-16 16:42:17 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2024-07-08 | Sell | 1,758 | 14.95 | 26,282 | 2024-07-10 16:34:42 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO | 2024-06-13 | Sell | 1,000 | 16.17 | 16,174 | 2024-06-14 16:32:12 |
| TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Directior | 2024-06-03 | Option Exercise | 11,918 | 6.06 | 72,223 | 2024-06-05 16:31:34 |
| TRDA | Entrada Therapeutics, Inc. | Sethuraman Natarajan | Chief Scientific Officer | 2024-05-16 | Sell | 18,980 | 15.16 | 287,695 | 2024-05-20 17:26:05 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO | 2024-05-16 | Sell | 3,000 | 15.04 | 45,129 | 2024-05-20 17:21:58 |
| TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Directior | 2024-05-14 | Buy | 25,000 | 14.59 | 364,673 | 2024-05-16 16:33:48 |
| TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Directior | 2024-05-08 | Buy | 4,476 | 14.14 | 63,306 | 2024-05-10 16:35:37 |
| TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Directior | 2024-04-08 | Buy | 2,600 | 13.57 | 35,290 | 2024-04-10 16:35:18 |
| TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Directior | 2024-03-28 | Buy | 1,512 | 13.75 | 20,794 | 2024-04-01 16:31:27 |
| TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Directior | 2024-03-22 | Buy | 9,048 | 13.58 | 122,882 | 2024-03-26 17:57:20 |
| TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Directior | 2024-03-19 | Buy | 2,732 | 12.81 | 34,996 | 2024-03-21 16:31:20 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2024-03-15 | Option Exercise | 9,000 | 2.10 | 18,900 | 2024-03-19 16:33:12 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2024-03-06 | Sell | 4,086 | 12.31 | 50,285 | 2024-03-08 16:36:21 |
| TRDA | Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | 2024-03-06 | Sell | 1,826 | 12.32 | 22,499 | 2024-03-08 16:34:26 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO | 2024-02-15 | Sell | 1,000 | 15.00 | 15,000 | 2024-02-20 16:37:38 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO | 2024-01-16 | Sell | 1,000 | 15.99 | 15,990 | 2024-01-18 16:32:35 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2023-12-21 | Sell | 12,500 | 15.59 | 194,845 | 2023-12-26 16:35:17 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2023-12-21 | Option Exercise | 12,500 | 2.10 | 26,250 | 2023-12-26 16:35:17 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-12-20 | Sell | 1,000 | 15.00 | 15,000 | 2023-12-22 16:38:24 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-11-13 | Sell | 1,000 | 16.23 | 16,230 | 2023-11-13 16:35:44 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-10-17 | Sell | 1,000 | 15.00 | 15,000 | 2023-10-19 17:27:51 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-09-13 | Sell | 1,000 | 15.00 | 15,000 | 2023-09-15 16:21:44 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2023-09-01 | Sell | 950 | 13.48 | 12,806 | 2023-09-06 17:11:05 |
| TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Officer | 2023-09-01 | Sell | 892 | 13.48 | 12,022 | 2023-09-06 17:08:54 |
| TRDA | Entrada Therapeutics, Inc. | Dowden Nathan J | Chief Operating Officer | 2023-09-01 | Sell | 972 | 13.47 | 13,089 | 2023-09-06 17:07:32 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-08-14 | Sell | 1,000 | 15.67 | 15,671 | 2023-08-16 16:32:35 |
| TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Officer | 2023-08-02 | Sell | 26,710 | 14.76 | 394,219 | 2023-08-04 16:50:05 |
| TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Officer | 2023-08-02 | Option Exercise | 26,710 | 2.10 | 56,091 | 2023-08-04 16:50:05 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2023-07-10 | Sell | 10,000 | 17.99 | 179,862 | 2023-07-12 16:34:51 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2023-07-10 | Option Exercise | 10,000 | 2.10 | 21,000 | 2023-07-12 16:34:51 |
| TRDA | Entrada Therapeutics, Inc. | Dowden Nathan J | Chief Operating Officer | 2023-07-10 | Sell | 7,097 | 18.03 | 127,938 | 2023-07-12 16:33:27 |
| TRDA | Entrada Therapeutics, Inc. | Sethuraman Natarajan | Chief Scientific Officer | 2023-07-10 | Sell | 17,878 | 18.03 | 322,389 | 2023-07-12 16:32:08 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2023-06-29 | Option Exercise | 8,790 | 2.10 | 18,459 | 2023-06-30 16:32:59 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2023-06-21 | Sell | 17,500 | 15.01 | 262,648 | 2023-06-23 16:20:25 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2023-06-21 | Option Exercise | 17,500 | 2.10 | 36,750 | 2023-06-23 16:20:25 |
| TRDA | Entrada Therapeutics, Inc. | Dowden Nathan J | Chief Operating Officer | 2023-06-20 | Sell | 15,982 | 15.42 | 246,403 | 2023-06-22 16:46:08 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-04-27 | Sell | 2,000 | 13.71 | 27,422 | 2023-05-01 16:38:26 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-04-17 | Sell | 2,092 | 18.01 | 37,675 | 2023-04-19 18:07:44 |
| TRDA | Entrada Therapeutics, Inc. | Sethuraman Natarajan | Chief Scientific Officer | 2023-04-17 | Sell | 3,961 | 18.00 | 71,316 | 2023-04-19 18:06:07 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-03-27 | Sell | 2,000 | 14.72 | 29,435 | 2023-03-29 17:12:30 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2023-03-01 | Sell | 1,747 | 10.53 | 18,389 | 2023-03-03 16:37:35 |
| TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Officer | 2023-03-01 | Sell | 1,641 | 10.56 | 17,336 | 2023-03-03 16:32:04 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-02-28 | Sell | 2,000 | 12.00 | 24,000 | 2023-03-02 16:36:27 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-01-27 | Sell | 2,000 | 12.00 | 24,001 | 2023-01-30 16:32:53 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2023-01-09 | Sell | 2,410 | 15.02 | 36,196 | 2023-01-10 16:40:20 |
| TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Officer | 2022-12-30 | Sell | 5,200 | 13.45 | 69,932 | 2023-01-03 16:32:21 |
| TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | President and CEO | 2022-12-27 | Sell | 14,590 | 15.02 | 219,119 | 2022-12-29 16:51:07 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2022-12-08 | Sell | 4,550 | 18.95 | 86,238 | 2022-12-12 16:36:42 |
| TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | 2022-12-08 | Option Exercise | 4,550 | 2.10 | 9,555 | 2022-12-12 16:36:42 |
